71 related articles for article (PubMed ID: 12532802)
1. [On the mechanisms of cardiac hypertrophy].
Pan DS; Tian C; Chen LY
Sheng Li Ke Xue Jin Zhan; 1999 Apr; 30(2):113-7. PubMed ID: 12532802
[TBL] [Abstract][Full Text] [Related]
2. Regulation of mitochondrial proliferation in the heart: power-plant failure contributes to cardiac failure in hypertrophy.
Goffart S; von Kleist-Retzow JC; Wiesner RJ
Cardiovasc Res; 2004 Nov; 64(2):198-207. PubMed ID: 15485678
[TBL] [Abstract][Full Text] [Related]
3. Familial hypertrophic cardiomyopathy: clinical features, molecular genetics and molecular genetic testing.
Taylor MR; Carniel E; Mestroni L
Expert Rev Mol Diagn; 2004 Jan; 4(1):99-113. PubMed ID: 14711353
[TBL] [Abstract][Full Text] [Related]
4. [Genetics and molecular biology of cardiac hypertrophy].
Rossi G; Cecchi F
G Ital Cardiol; 1995 Dec; 25(12):1643-8. PubMed ID: 8707013
[No Abstract] [Full Text] [Related]
5. Lack of JunD promotes pressure overload-induced apoptosis, hypertrophic growth, and angiogenesis in the heart.
Hilfiker-Kleiner D; Hilfiker A; Kaminski K; Schaefer A; Park JK; Michel K; Quint A; Yaniv M; Weitzman JB; Drexler H
Circulation; 2005 Sep; 112(10):1470-7. PubMed ID: 16129800
[TBL] [Abstract][Full Text] [Related]
6. Familial hypertrophic cardiomyopathy-linked mutant troponin T causes stress-induced ventricular tachycardia and Ca2+-dependent action potential remodeling.
Knollmann BC; Kirchhof P; Sirenko SG; Degen H; Greene AE; Schober T; Mackow JC; Fabritz L; Potter JD; Morad M
Circ Res; 2003 Mar; 92(4):428-36. PubMed ID: 12600890
[TBL] [Abstract][Full Text] [Related]
7. Hypertrophy, fibrosis, and sudden cardiac death in response to pathological stimuli in mice with mutations in cardiac troponin T.
Maass AH; Ikeda K; Oberdorf-Maass S; Maier SK; Leinwand LA
Circulation; 2004 Oct; 110(15):2102-9. PubMed ID: 15466629
[TBL] [Abstract][Full Text] [Related]
8. Molecular insights from a novel cardiac troponin I mouse model of familial hypertrophic cardiomyopathy.
Tsoutsman T; Chung J; Doolan A; Nguyen L; Williams IA; Tu E; Lam L; Bailey CG; Rasko JE; Allen DG; Semsarian C
J Mol Cell Cardiol; 2006 Oct; 41(4):623-32. PubMed ID: 16950368
[TBL] [Abstract][Full Text] [Related]
9. Severe heart failure and early mortality in a double-mutation mouse model of familial hypertrophic cardiomyopathy.
Tsoutsman T; Kelly M; Ng DC; Tan JE; Tu E; Lam L; Bogoyevitch MA; Seidman CE; Seidman JG; Semsarian C
Circulation; 2008 Apr; 117(14):1820-31. PubMed ID: 18362229
[TBL] [Abstract][Full Text] [Related]
10. Activation of histone deacetylase 2 by inducible heat shock protein 70 in cardiac hypertrophy.
Kee HJ; Eom GH; Joung H; Shin S; Kim JR; Cho YK; Choe N; Sim BW; Jo D; Jeong MH; Kim KK; Seo JS; Kook H
Circ Res; 2008 Nov; 103(11):1259-69. PubMed ID: 18849323
[TBL] [Abstract][Full Text] [Related]
11. Cardiac hypertrophy, substrate utilization and metabolic remodelling: cause or effect?
Ritchie RH; Delbridge LM
Clin Exp Pharmacol Physiol; 2006; 33(1-2):159-66. PubMed ID: 16445716
[TBL] [Abstract][Full Text] [Related]
12. Male sex aggravates the phenotype in mouse models of hypertrophic cardiomyopathy.
Maass AH; Maier SK
Herz; 2005 Aug; 30(5):405-8. PubMed ID: 16132243
[TBL] [Abstract][Full Text] [Related]
13. [Cardiocirculatory regulation in heart hypertrophy].
Dickhuth HH
Fortschr Med; 1986 Jan; 104(3):38-42. PubMed ID: 2937702
[No Abstract] [Full Text] [Related]
14. Gi alpha 1-mediated cardiac electrophysiological remodeling and arrhythmia in hypertrophic cardiomyopathy.
Ruan H; Mitchell S; Vainoriene M; Lou Q; Xie LH; Ren S; Goldhaber JI; Wang Y
Circulation; 2007 Aug; 116(6):596-605. PubMed ID: 17646583
[TBL] [Abstract][Full Text] [Related]
15. The role of the AT1 angiotensin receptor in cardiac hypertrophy: angiotensin II receptor or stretch sensor?
Hunyady L; Turu G
Trends Endocrinol Metab; 2004 Nov; 15(9):405-8. PubMed ID: 15519886
[TBL] [Abstract][Full Text] [Related]
16. Expression profiling reveals differences in metabolic gene expression between exercise-induced cardiac effects and maladaptive cardiac hypertrophy.
Strøm CC; Aplin M; Ploug T; Christoffersen TE; Langfort J; Viese M; Galbo H; Haunsø S; Sheikh SP
FEBS J; 2005 Jun; 272(11):2684-95. PubMed ID: 15943803
[TBL] [Abstract][Full Text] [Related]
17. Behavior of both epicardial and intramural coronary artery flow velocities in various models of myocardial hypertrophy: role for left ventricular outflow tract obstruction.
de Gregorio C; Micari A; Grimaldi P; Bragadeesh T; Arrigo F; Coglitore S
Am Heart J; 2005 Jun; 149(6):1091-8. PubMed ID: 15976793
[TBL] [Abstract][Full Text] [Related]
18. Role of apoptosis in pressure-overload cardiomyopathy.
Anselmi A; Gaudino M; Baldi A; Vetrovec GW; Bussani R; Possati G; Abbate A
J Cardiovasc Med (Hagerstown); 2008 Mar; 9(3):227-32. PubMed ID: 18301137
[TBL] [Abstract][Full Text] [Related]
19. Early and transient gene expression changes in pressure overload-induced cardiac hypertrophy in mice.
van den Bosch BJ; Lindsey PJ; van den Burg CM; van der Vlies SA; Lips DJ; van der Vusse GJ; Ayoubi TA; Doevendans PA; Smeets HJ
Genomics; 2006 Oct; 88(4):480-8. PubMed ID: 16781840
[TBL] [Abstract][Full Text] [Related]
20. Fatty acid metabolism assessed by 125I-iodophenyl 9-methylpentadecanoic acid (9MPA) and expression of fatty acid utilization enzymes in volume-overloaded hearts.
Miyamoto T; Takeishi Y; Tazawa S; Inoue M; Aoyama T; Takahashi H; Arimoto T; Shishido T; Tomoike H; Kubota I
Eur J Clin Invest; 2004 Mar; 34(3):176-81. PubMed ID: 15025675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
